Tessera Therapeutics

Valuation: $1.69 Billion

Founded: 2018

City: Cambridge

Country: United States

Industry: Healthcare & Life Sciences

Description: Biotechnology company focused on gene writing technology to cure diseases by precisely writing in any kind of genetic change into a patient's DNA.